Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

A woman with severe angioedema improved significantly after treatment with rituximab.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Upadacitinib may effectively treat resistant lichen planopilaris.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

A patient with complete hair loss regrew all her hair using tofacitinib.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Social media can help compare the effectiveness and safety of new arthritis medications.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Dimethyl-fumarate may cause temporary hair loss.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

ZD1839 can cause skin issues like acne and hair changes.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Dupilumab users have a higher risk of developing alopecia areata.

Flumethasone causes wool shedding in Merino wethers, with recovery in about 60 days.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

IL-17 and IL-23 inhibitors can cause skin reactions that may require different treatments.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.